Stock Review: OPTO CIRCUITS

Opto Circuits has been one of the fastest-growing companies in the healthcare sector. This export-oriented undertaking has been charting strong growth through sale of invasive cardiovascular and peripheral devices. Strong performance of Eurocor, its German subsidiary, and Criticare, US subsidiary, has also contributed to the company's growth. Through its German acquisition, the company has been supplying the invasive devices across Europe and Asia at a lower cost. The invasive business segment is the long-term growth driver for the company. Opto commands premium valuations on the bourses, which are justifiable in view of the high growth prospects. Its stock is trading at a consolidated P/E of 16.5.